GDM is defined as glucose intolerance on first recognition during pregnancy [63] and characteristically shows altered plasma adipokine levels, inflammation, deregulation of the insulin signaling pathway, and oxidative stress [64,65,66]. This evidence concerns the gene INS and gestational diabetes.